Course Category: General

Integrating 3D printing and biofabrication in breast implants and reconstruction represents a significant innovation in medical technology. Using biocompatible materials and advanced printing techniques, these implants can be customized to match the unique anatomical features of each patient. Unlike traditional implants, biofabricated breast implants have the potential to mimic natural tissue more closely, reducing complications and improving aesthetic outcomes. This technology also allows for the incorporation of living cells, which could enable the regeneration of breast tissue, offering a groundbreaking approach to reconstructive and cosmetic surgery. The convergence of 3D printing and biofabrication is poised to revolutionize the future of breast augmentation and reconstruction.

Speakers:

Mohit Chhaya

Mohit P. Chhaya, PhD, is a biomedical engineer with a career marked by pioneering contributions to biofabrication and tissue engineering. A Queensland University of Technology alum, Dr. Chhaya has authored numerous Q1 top-tier journal publications and developed cutting-edge technologies licensed by leading 3D BioPrinter manufacturers. As the co-founder and CEO of BellaSeno, he successfully raised EUR 17 million, steering the company towards ISO 13485 certification and steering its flagship product, Senella, through clinical translation. His tenure at BellaSeno also involved transforming it into a multi-product company and achieving market authorization for innovative best-in-class regenerative scaffolds. Before founding BellaSeno, Dr. Chhaya co-founded Biofabrication Design Solutions, focusing on additive manufacturing for multi-material constructs. His professional journey includes roles in regulatory affairs, postdoctoral research, and financial analysis, demonstrating a broad skill set beyond bioengineering. Dr. Chhaya’s innovations have garnered international recognition, earning him prestigious awards such as the MIT Top 20 Innovators Under 35 and the German Innovation Award 2021. An active member of the ASTM Committee on Additive Manufacturing and a respected speaker at international conferences, Dr. Chhaya is deeply involved in advancing biofabrication standards and education. His remarkable IP portfolio includes numerous patents and designs across various jurisdictions, underscoring his contribution to medical technology innovation.

Julien Payen

Julien Payen is a Biomaterials Engineer who began his career with contributions to respiratory devices by working on nanofibers development for air filtration. Then he worked successively as R&D manager for a multinational company in protective devices and in the finance of innovative projects in medical devices. He founded Lattice Medical in late 2017 with two medical doctors and a plastic surgeon to bring an alternative to the breast reconstruction landscape with a 3D printed and bioabsorbable implant, MATTISSE. He successfully raised EUR 20 million with Lattice Medical, gathering a team of 25 engineers, PhDs and complete successful milestones such as ISO 13485:2016 certification, the establishment of a 3D printing farm production facility in a clean room to produce our devices and bringing their lead product MATTISSE, through clinical trials. Thanks to his impetus, he has enabled Lattice Medical to become a medical company developing several medical products (breast: MATTISSE, skin: RODIN) as well as medical-grade raw materials for 3D printing (LATTICE SERVICES). He has earned several awards such as Start-Up of the year by the Challenges magazine in France or apart of Medtech Innovator cohort 2024 or nominee of the prestigious Galien Prize in New York in 2023.

Jeong Hun Park

Dr. Jeong Hun Park is a Research Scientist in the Wallace H. Coulter Department of Biomedical Engineering and Center for 3D Medical Fabrication at Georgia Institute of Technology and Emory University. Since starting his academic career as a Research Scientist I in 2019, Dr. Park has performed various research focusing on the development of advanced functional medical devices using 3D bioprinting and biomechanics for a wide range of biomedical applications, including tissue engineering, disease treatment, and biomimetic in vitro tissue model for diagnosis.

Xue Dong

Dr. Xue Dong is a dedicated researcher specializing in tissue engineering and its applications in surgery. Her interest in the field began as a medical student at Weill Cornell Medical College, where she worked on collagen-based microspheres for prenatal cleft lip repair and dermal substitutes for wound healing. This experience deepened her understanding of scientific inquiry in relation to clinical practice. Since her general surgery residency, Dr. Dong has been focused on breast cancer-related research, addressing challenges faced by patients undergoing surgery and reconstruction. Her work includes evaluating treatment effects through data analysis, optimizing 3D-printed biomaterial scaffolds for reconstruction, and exploring fat grafting techniques for soft tissue enhancement.

Moderator: 

Dr. Jenny Chen

Dr. Jenny Chen is trained as a neuroradiologist, and founder/CEO of 3DHEALS. Her main interests include next-generation education, 3D printing in the healthcare sector, automated biology, and artificial intelligence. She is an angel investor who invests in Pitch3D companies.

This annual virtual event dedicated to biomaterials and material science for 3D printing implants, medical devices, and biofabrication presents a unique and compelling opportunity for individuals across various disciplines to delve into the cutting-edge advancements shaping the future of healthcare. With the demand for innovative solutions in implantology and tissue engineering on the rise, this event serves as a pivotal platform for researchers, engineers, clinicians, entrepreneurs, and industry professionals to explore the latest breakthroughs and methodologies in biomaterials science. Attendees will have the chance to gain invaluable insights into the development of novel materials, fabrication techniques, and biofunctionalization strategies tailored for applications in 3D printing implants, medical devices, and biofabrication. From elucidating the fundamental properties of biomaterials to showcasing innovative approaches for enhancing biocompatibility, mechanical properties, and bioactivity of implants, this event offers a comprehensive overview of the current state-of-the-art in material science for medical applications. Moreover, the virtual format ensures accessibility to a global audience, facilitating networking opportunities and knowledge exchange among professionals from diverse backgrounds and regions.

Speakers:

Rao Bezwada

An accomplished scientist and entrepreneur, Rao S. Bezwada, Ph.D. established Bezwada Biomedical, an innovation-based and technology-driven research company, in 2003. The company is focused on developing a wide range of novel absorbable polymeric biomaterials to enhance quality of life by producing next generation bioabsorbable medical devices with therapeutic applications. Dr. Bezwada earned a doctorate in chemistry from the Stevens Institute of Technology in New Jersey and has over 40 years of research experience in the medical device industry, including 20 years of service at Ethicon, Inc. (a Johnson & Johnson Company). While at Ethicon, Dr. Bezwada’s research and development efforts led to the launch of a number of products, including Monocryl®, a new ultra-pliable synthetic absorbable monofilament suture. This product has represented worldwide sales of more than two (2) billion dollars since its launch in 1993 and current annual sales of over 100 million dollars. In recognition of this invention, along with its development, Johnson & Johnson, Inc. awarded Dr. Bezwada the prestigious Johnson Medal in 1996. Dr. Bezwada has been a prolific inventor and has been issued more than 135 U.S. patents on absorbable polyurethanes, absorbable amino acid polymers, absorbable polyester amides, absorbable polyoxaesters, and controlled release polymers. FDA-approved products such as MONTAGE® Putty, MONTAGE Fast Set Putty, Montage Flowable Putty, and PERMATAGE Putty, marketed by Abyrx for wound healing and bone applications, are based on Bezwada Biomedical’s absorbable polyurethane technology. Dr. Bezwada has also pioneered specialty bio-inks for 3D printing applications. In addition to his passion for science and technical accomplishments, Dr. Bezwada has also established a non-profit organization, Society for Basic Needs, in India. This organization has a mission aimed at improving the quality of life for those less fortunate by providing them with essential amenities and opportunities for health and education.

Mohammad Albanna, PhD

Dr. Albanna is the founder and CEO of Humabiologics, one of the only regenerative medicine companies focused on developing and commercializing human-derived biomaterials to researchers around the world for regenerative medicine applications. He holds a PhD in Biomedical Engineering, 2 master’s degrees in Materials Sciences and Electrical & Computer Engineering and completed a postdoctoral fellowship at Wake Forest Institute of Regenerative Medicine, where he served as the lead of the skin bioprinting group and is currently an adjunct assistant professor of Surgery at Atrium Health Wake Forest Baptist. Dr. Albanna authored several peer-reviewed papers, book chapters and is the inventor of several issued and patent-pending applications. Dr. Albanna has 15 years of industry experience, during which he has held several senior and executive leadership positions across several industries including medical devices, blood banking, and tissue banking. His work in regenerative medicine was recognized through several prestigious awards including 2013 Thomas Edison Gold Award in Innovation, 2018 Arizona Innovator of the year finalist, and 2021 Arizona Leader in Innovation Award.

Anis Hadj Henni

As CEO, Anis Hadj Henni oversees Rheolution’s development strategy over the Life Sciences and Agri-Food business units. He is also in charge of the customer experience and key partnerships with strategic business partners, distributors and investors. Anis works closely with Rheolution’s sales, operations and engineering teams to provide the best instruments, software and services to customers. As an entrepreneur, Anis is driven by a powerful purpose: ‘‘My team and I are on the mission of ending the status quo in the analytical testing space that limits our customer’s ability to innovate and create value for the benefit of people’s health and nutrition. We are defining, with our community of users, Soft Matter Analytics as the paradigm that will shape the future of analytical instrumentation. And, because an idea is not enough, we gathered an outstanding and talented team that works hard to make Soft Matter Analytics a realty to our customers and communities’’, he says. After a successful career in research, Anis co-founded Rheolution in 2009 with new ideas and a vision of what the future could look like. A decade after, he is extremely proud of seeing customers, colleagues, business partners and stakeholders sharing, enriching and building that vision. Anis graduated in civil engineering from the National Polytechnic School of Algiers (Algeria) and holds a Ph.D. in mechanics from Université de Bordeaux (France).

Annaliese Vojnich

Meet Annaliese Vojnich, a dynamic business development and technical sales manager currently overseeing the Puredyne® brand and the Hygienic Solutions division for ViscoTec America. Annaliese’s professional journey spans various industries, including sales, pharmaceuticals, medical technology, research and development, and hygienic FDA manufacturing, equipping her with a versatile skill set that stands at the forefront. Earning a bachelor’s degree in Dietetics/Nutritional Sciences from the esteemed University of Georgia in 2018, Annaliese’s academic foundation underscores her commitment to knowledge and growth. Her pursuit of education extended further with a Certificate in Women’s Entrepreneurship from Cornell University, where she refined her leadership abilities in 2022. Annaliese’s passion for biotechnology began in 2014 at the Center for Applied Genetic Technologies, a University of Georgia facility. During her time as an assistant lab manager and research assistant, her responsibilities were concentrated on genetic transformation, somatic embryogenesis, plant breeding and genetics, and tissue culture management. Annaliese’s foundation has positioned her to excel not only in sales and management roles but also in bridging the gap between innovation and real-world applications. Her current role at ViscoTec America, where she contributes to cutting-edge dosing technology and bioprinting advancements, showcases her ability to merge her passion for science with her sales acumen.

Ferry Melchels

Ferry Melchels is the research professor of Biomaterials and Tissue Engineering at the Future Industries Institute at the University of South Australia in Adelaide. His main interests lie in polymeric biomaterials for 3D printing, tissue engineering, and drug and vaccine delivery. His work has been published in leading journals, attracting over 17,000 citations. He is a recipient of the Patrick Neill Medal for Early Career Researchers in the Life Sciences from the Royal Society of Edinburgh (2020), and the Mid-Career Investigator Award from the International Society for Biofabrication (2019). Ferry holds an MSc (2005) in chemical engineering and PhD (2010) in biomaterials from the University of Twente (The Netherlands). He was a Marie Curie post-doctoral fellow between two of the pioneering institutes in Biofabrication; Queensland University of Technology (Brisbane, Australia) and University Medical Center Utrecht (The Netherlands) and held his first PI position at Heriot-Watt University in Edinburgh (UK) from 2015-2023. Besides home brewing the best beers on the weekend, his future aim is to continue advancing materials-based technology platforms for biomedical applications.

Moderator:

Dr. Jenny Chen

Dr. Jenny Chen is trained as a neuroradiologist, and founder/CEO of 3DHEALS. Her main interests include next-generation education, 3D printing in the healthcare sector, automated biology, and artificial intelligence. She is an angel investor who invests in Pitch3D companies.

Led by clinical and technical experts from major institutions in the US, EU, and Singapore, this event aims to update all stakeholders on everything about point-of-care 3D printing. From personalized surgical tools to anatomical models for preoperative planning, participants will discover how this technology is revolutionizing patient care by bringing manufacturing capabilities directly to the bedside. Speakers and the audience will join a conversation on the current status and future direction of this new way of care delivery.

Speakers:

Shannon Walters

Shannon Walters is an innovation enabler and workflow optimization enthusiast. At Stanford 3D and Quantitative Imaging Lab, Shannon works closely with healthcare providers, researchers, and educators to enable effective health visualization. Recent innovations are of particular interest to Shannon such as AI in Medical Imaging, Virtual/Augmented Reality, 3D Printing, and longitudinal assessment of complex disease processes.

Chris LeCastillo

Chris LeCastillo is the Innovations Manager of the Stanford 3D and Quantitative Imaging Laboratory, where he is a Radiologic Technologist and a Certified Imaging Informatics Professional. He helps drive forward meaningful innovations in 3D printing, medical imaging AI, and manages the XR Neurosurgical Navigation program at Stanford. Chris holds a Bachelor of Science in Health Information Management and a Master of Health Leadership.

Mark Tan

Dr. Mark Tan is a Radiologist and the Clinical Lead of the Singapore General Hospital 3D Printing Centre. Dr Tan enjoys working with clinical teams on virtual surgical planning for head and neck, plastic and reconstructive, neurosurgical, oncological, orthopaedic and cardiac surgeries. Dr Tan also enjoys working with clinical teams, imagers, engineers, administrators, academia and industry in designing and producing from medical imaging patient-specific anatomical models for surgical rehearsal and implant sizing, surgical guides for localisation and reconstruction, bespoke orthotics and prosthetics, as well as custom implants, to improve clinical care.

Neha Sharma

Dr. Neha Sharma, PhD, is the Deputy Head of the Medical Additive Manufacturing (Swiss MAM) Research Group and the 3D Print Lab at University Hospital Basel, Switzerland. With a background in Craniomaxillofacial (CMF) Surgery from India and a PhD in Biomedical Engineering from the University of Basel, Switzerland, Dr. Sharma brings extensive expertise in CMF trauma, reconstructive, and orthognathic surgeries. Her work focuses on integrating digital technologies like medical 3D printing and VR/AR into clinical practice, pioneering computer-assisted virtual surgical planning, and exploring novel biomaterials for reconstructive surgeries.

Brian Overshiner

Brian Overshiner is a distinguished radiation therapist and 3D printing expert with over 20 years of experience in the medical field. His journey into the realm of 3D printing was driven by his passion for technology and innovation. In 2015, Brian spearheaded the creation of the IU Health 3D Innovations Lab, enabling Indiana University Health to become one of the first clinical sites to offer personalized 3D printed radiotherapy treatment devices along with design, prototyping and advanced visualization.
Currently, Brian serves as the onsite manager of the Ricoh 3D for Healthcare Innovation Studio in Winston-Salem, NC. This flagship HIPAA compliant, ISO 14485-certified Point of Care 3D medical device manufacturing facility provides immediate access to development, design, and manufacturing services for patient-specific 3D printed anatomical models used in surgical planning and patient education.

This virtual event centered on biofabrication and bioprinting of musculoskeletal tissue. As the demand for effective treatments for bone and cartilage defects continues to rise with an aging population, this event is a vital platform for deep conversations about the challenges, progress, and future of tissue engineering for regenerative purposes in treating orthopedic diseases. By attending, participants will gain invaluable insights into the cutting-edge technologies and methodologies driving the development of innovative treatments for musculoskeletal diseases. Throughout the event, attendees will have the chance to engage with leading experts in the field, who will share their expertise and firsthand experiences in both the scientific and commercialization aspects of the field.  Moreover, the virtual format ensures accessibility to a global audience, fostering collaboration and knowledge exchange among professionals from diverse backgrounds and regions. Don’t miss your chance to be part of this transformative event shaping the future of musculoskeletal tissue engineering and regenerative medicine.

Speakers:

Y. Shrike Zhang

Dr. Zhang is an Associate Professor in the Department of Medicine at Harvard Medical School and Associate Bioengineer in the Division of Engineering in Medicine at the Brigham and Women’s Hospital. He is directing the Laboratory of Engineered Living Systems (www.shrikezhang.com), where the research is focused on innovating medical engineering technologies, including 3D bioprinting, organs-on-chips, microfluidics, and bioanalysis, to recreate functional tissues and their biomimetic models, for applications in regenerative medicine and personalized medicine. Dr. Zhang is an author of >330 peer-reviewed publications (>50 covers; citations ~35,000, h-index = 92). His scientific contributions have been recognized by >45 awards.

Brad Estes

Dr. Estes received his Ph.D. from Duke University in Biomedical Engineering with an emphasis in chondrogenesis of fat-derived stem cells. Before earning his Ph.D., Brad served as the Manager of Research and Development in the spinal orthopedic division of Medtronic where he oversaw commercialization of medical devices from conception to market, including the achievement of regulatory approval for class III medical devices. He was also integrally involved in seeking intellectual property protection for the innovative products Medtronic was producing. In addition, Dr. Estes has acted as a consultant for both small and large medical device companies. In total, he has over 25 years of industry experience and holds 55 patents associated with medical devices. In his current role, Brad oversees all aspects of CytexOrtho operations with a focus on growth and success. In this position, he provides strategic leadership and sets the vision and direction for the company. His responsibilities include guiding research and development efforts, forging strategic partnerships, securing funding, and ensuring regulatory compliance. Additionally, he plays a hands-on role in fostering a collaborative and dynamic work culture, driving motivation and creativity among the tight-knit team at CytexOrtho.

Flore-Anne Poujade

Dr. Poujade earned her PhD from the University of Hull, UK. During her academic career, she worked on several projects. Including deciphering the roles of growth factors and hypoxia in regulating chondrocytic phenotype in vitro, as well as creating an aorta on a chip model to better understand the mechanisms driving ascending aortic aneurysm. It was after her postdoc at the Karolinska Institute that she joined CELLINK where she now works as Senior Field Application Scientist. As such, over the past 3 years, she has advised numerous researchers on 3D bioprinting techniques and practices to help democratise the fabrication of more realistic research models.

Dr. Wilson Wong

Wilson is a healthcare-focused entrepreneur with a PhD, MPhil, and BEng from the University of Hong Kong, specializing in biomechanics, biomaterials, and bone-related diseases. He also completed technopreneurship training at IECT, University of Cambridge, supported by Dr. Hermann Hauser. In 2014, he founded NOVUS Life Sciences Limited, where he currently serves as Chairman and CEO. NOVUS, a global leader in 3D printing biomaterials, operates cutting-edge manufacturing facilities in Hong Kong and Shenzhen. The company supplies to 35+ countries and 65+ corporate clients, supporting the production of patient-specific implants and devices. Wilson is actively engaged in the startup ecosystem and dedicated to fostering entrepreneurship education. He has been a featured speaker and lecturer at institutions and Bloomberg. Under his leadership, NOVUS has received numerous prestigious awards, including Champion of IMAGINE IF!, CNBC’s hottest startups, and accolades from GIN Austria, French Tech Ticket, and Alibaba Jumpstarter.

Moderator:

Dr. Jenny Chen

Dr. Jenny Chen is trained as a neuroradiologist, and founder/CEO of 3DHEALS. Her main interests include next-generation education, 3D printing in the healthcare sector, automated biology, and artificial intelligence. She is an angel investor who invests in Pitch3D companies.

What is the next frontier of medical device and biotech innovation?  Don’t miss this upcoming virtual event, “3D Microfabrication 2.0.” Joined by leading experts and pioneers in the field, this event promises to unveil the transformative potential of 3D microfabrication techniques in revolutionizing the landscape of medical device manufacturing. From intricate implants to specialized instruments, participants will gain exclusive insights into how micro or nano-scale 3D printing is reshaping the design, production, and functionality of medical devices with unprecedented precision and efficiency at a micro-scale using a variety of biomaterials. Could bio-chips (microfluidics devices), robotic and endoscopic tips, and microneedles be the next frontier of international technological competition like that for the semiconductor industry? Join the conversation live and find out!

Speakers:

Dr. Benjamin Richter

Benjamin Richter is an Application Manager at Nanoscribe and develops microfabrication processes and applications for the life sciences. Before, he completed an interdisciplinary PhD thesis on “Selective Biofunctionalization of 3D Microstructures” in the groups of Prof. Wegener, Prof. Bastmeyer and Prof. Barner-Kowollik at KIT. His scientific papers have been cited more than 1500 times (Google Scholar).

Chunguang Xia

CTO and co-founder of Boston Micro Fabrication (BMF). Chunguan was trained as a mechanical engineer and worked in the semiconductor equipment industry for eight years before starting BMF Precision. Recently, BMF Biotechnology Inc. developed biochips for in vitro drug testing.

Jungho Choi

Jungho is a Ph.D candidate at Gatech with a background in mechanical engineering. His research is specialized in micro/nanoscale manufacturing. I aim to develop a new metal/polymer additive manufacturing system and generate the processing science for a rapid and cost-effective nanoscale fabrication system.

Talk title, “Scalable printing of metal nanostructures through superluminescent light projection”

Moderator:

Dr. Jenny Chen

Dr. Jenny Chen is trained as a neuroradiologist, and founder/CEO of 3DHEALS. Her main interests include next-generation education, 3D printing in the healthcare sector, automated biology, and artificial intelligence. She is an angel investor who invests in Pitch3D companies.